Trial · NCT03038022
Results by group53
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 53
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Percent Change in LDL-C From Baseline To Week 12 | MGL-3196 | -10.6 | Standard Error 2.59 | percent change | |
| Mean Percent Change in LDL-C From Baseline To Week 12 | Placebo | 8.2 | Standard Error 3.71 | percent change | |
| Mean Change From Baseline to Week 12 of Free Thyroxine (T4) | MGL-3196 | -0.268 | Standard Error 0.0130 | ng/dL | |
| Mean Change From Baseline to Week 12 of Free Thyroxine (T4) | Placebo | 0.009 | Standard Error 0.0185 | ng/dL | |
| Mean Change From Baseline to Week 12 of Free Triiodothyronine (T3) | MGL-3196 | -0.04 | Standard Error 0.038 | ng/L | |
| Mean Change From Baseline to Week 12 of Free Triiodothyronine (T3) | Placebo | 0.10 | Standard Error 0.054 | ng/L | |
| Mean Change From Baseline to Week 12 of Thyrotropin (TSH) | MGL-3196 | -0.027 | Standard Error 0.0690 | mIU/L | |
| Mean Change From Baseline to Week 12 of Thyrotropin (TSH) | Placebo | 0.114 | Standard Error 0.0987 | mIU/L | |
| Mean Change From Baseline to Week 12 of Thyroxine Binding Globulin (TBG) | MGL-3196 | -2.31 | Standard Error 0.256 | mg/L | |
| Mean Change From Baseline to Week 12 of Thyroxine Binding Globulin (TBG) | Placebo | -0.44 | Standard Error 0.367 | mg/L | |
| Mean Change From Baseline to Week 12 of Reverse Triiodothyronine (T3) | MGL-3196 | -4.36 | Standard Error 0.392 | ng/dL | |
| Mean Change From Baseline to Week 12 of Reverse Triiodothyronine (T3) | Placebo | -0.58 | Standard Error 0.554 | ng/dL | |
| Mean Percent Change in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) From Baseline to Week 12 | MGL-3196 | -12.0 | Standard Error 2.41 | percent change | |
| Mean Percent Change in Non-high-density Lipoprotein Cholesterol (Non-HDL-C) From Baseline to Week 12 | Placebo | 7.5 | Standard Error 3.46 | percent change | |
| Mean Percent Change In Triglycerides From Baseline To Week 12 | MGL-3196 | -18.3 | Standard Error 3.24 | percent change | |
| Mean Percent Change In Triglycerides From Baseline To Week 12 | Placebo | 7.2 | Standard Error 4.64 | percent change | |
| Mean Percent Change In Lipoprotein(a) (Lp[a]) From Baseline To Week 12 | MGL-3196 | -21.8 | Standard Error 2.87 | percent change | |
| Mean Percent Change In Lipoprotein(a) (Lp[a]) From Baseline To Week 12 | Placebo | 4.4 | Standard Error 4.11 | percent change | |
| Mean Percent Change in Apolipoprotein CIII From Baseline to Week 12 | MGL-3196 | -19.3 | Standard Error 2.9 | percent change | |
| Mean Percent Change in Apolipoprotein CIII From Baseline to Week 12 | Placebo | 3.4 | Standard Error 4.1 | percent change |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03038022/results